Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ovarian Epithelial

Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.

539 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ovarian Epithelial trial results

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT06395519

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)

NCT05827523

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Chungnam National University Hospital Sejong, Chungcheongnam-do, South Korea
  • Chungnam National University Sejong Hospital Sejong, Chungcheongnam-do, South Korea
  • Ilsan CHA University Hospital Goyang-si, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
View Trial Details
Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT06469281

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

NCT06690775

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • SCRI - Arizona Oncology Associates, PC-HOPE Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Providence St. Jude Medical Center Fullerton, California, United States
View all 66 locations
View Trial Details

Related conditions